Comment in

• Risk factors for bisphosphonate-related osteonecrosis of the jaws.

  Kyrgidis A, Vahtsevanos K. Kyrgidis A, et al. J Oral Maxillofac Surg. 2009 Nov;67(11):2553-4. doi: 10.1016/j.joms.2009.06.029. J Oral Maxillofac Surg. 2009. PMID: 19837340 No abstract available.
• American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.

  Colella G, Campisi G, Fusco V. Colella G, et al. J Oral Maxillofac Surg. 2009 Dec;67(12):2698-9. doi: 10.1016/j.joms.2009.07.097. J Oral Maxillofac Surg. 2009. PMID: 19925998 No abstract available.
• Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw?

  Yarom N, Fedele S, Lazarovici TS, Elad S. Yarom N, et al. J Oral Maxillofac Surg. 2010 Mar;68(3):705. doi: 10.1016/j.joms.2009.07.086. J Oral Maxillofac Surg. 2010. PMID: 20171493 No abstract available.
• Drug-related osteonecrosis of the jaws: "Exposure, or not exposure: that is the question".

  Mignogna MD, Sadile G, Leuci S. Mignogna MD, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 May;113(5):704-5. doi: 10.1016/j.oooo.2012.01.004. Epub 2012 Mar 3. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012. PMID: 22668630 No abstract available.